3153 related articles for article (PubMed ID: 7691291)
1. Expression of the chondroitin sulphate proteoglycan molecular complex in six human melanoma xenograft lines studied by flow cytometry and immunohistochemistry.
Nagelhus TA; Rofstad EK
Melanoma Res; 1993 Jun; 3(3):187-94. PubMed ID: 7691291
[TBL] [Abstract][Full Text] [Related]
2. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
Lyng H; Olsen DR; Petersen SB; Rofstad EK
NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
[TBL] [Abstract][Full Text] [Related]
3. Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity.
Erfurt C; Sun Z; Haendle I; Schuler-Thurner B; Heirman C; Thielemans K; van der Bruggen P; Schuler G; Schultz ES
J Immunol; 2007 Jun; 178(12):7703-9. PubMed ID: 17548607
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
Harper JR; Bumol TF; Reisfeld RA
J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
[TBL] [Abstract][Full Text] [Related]
5. The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface.
Garrigues HJ; Lark MW; Lara S; Hellström I; Hellström KE; Wight TN
J Cell Biol; 1986 Nov; 103(5):1699-710. PubMed ID: 2430975
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures.
Richards JO; Treisman J; Garlie N; Hanson JP; Oaks MK
Cytometry A; 2012 May; 81(5):374-81. PubMed ID: 22467596
[TBL] [Abstract][Full Text] [Related]
7. Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts.
Kopper L; Bankfalvi A; Mihalik R; Glant TT; Timar J
Cancer Immunol Immunother; 1990; 32(2):137-42. PubMed ID: 2289206
[TBL] [Abstract][Full Text] [Related]
8. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma.
Smetsers TF; van de Westerlo EM; ten Dam GB; Clarijs R; Versteeg EM; van Geloof WL; Veerkamp JH; van Muijen GN; van Kuppevelt TH
Cancer Res; 2003 Jun; 63(11):2965-70. PubMed ID: 12782604
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.
Yang HM; Reisfeld RA
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1189-93. PubMed ID: 3422487
[TBL] [Abstract][Full Text] [Related]
10. Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody IG2 in the rat cerebrum.
Oohira A; Matsui F; Watanabe E; Kushima Y; Maeda N
Neuroscience; 1994 May; 60(1):145-57. PubMed ID: 8052408
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of proteoglycan expression on murine tumor cells with different metastatic capacity.
Timár J; Lapis K
Anticancer Res; 1990; 10(3):785-7. PubMed ID: 1695080
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican.
Braunewell KH; Martini R; LeBaron R; Kresse H; Faissner A; Schmitz B; Schachner M
Eur J Neurosci; 1995 Apr; 7(4):792-804. PubMed ID: 7542529
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients.
Erfurt C; Müller E; Emmerling S; Klotz C; Hertl M; Schuler G; Schultz ES
Int J Cancer; 2009 May; 124(10):2341-6. PubMed ID: 19173283
[TBL] [Abstract][Full Text] [Related]
14. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
15. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.
Danen EH; Jansen KF; Van Kraats AA; Cornelissen IM; Ruiter DJ; Van Muijen GN
Int J Cancer; 1995 May; 61(4):491-6. PubMed ID: 7538977
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of a basement membrane-specific chondroitin sulfate proteoglycan.
McCarthy KJ; Accavitti MA; Couchman JR
J Cell Biol; 1989 Dec; 109(6 Pt 1):3187-98. PubMed ID: 2592422
[TBL] [Abstract][Full Text] [Related]
17. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches.
Morgan AC; Woodhouse C; Bartholemew R; Schroff R
Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids.
Rofstad EK; Eide K; Skøyum R; Hystad ME; Lyng H
Int J Radiat Biol; 1996 Sep; 70(3):241-9. PubMed ID: 8800195
[TBL] [Abstract][Full Text] [Related]
19. Blood flow in six human melanoma xenograft lines with different growth characteristics.
Lyng H; Skretting A; Rofstad EK
Cancer Res; 1992 Feb; 52(3):584-92. PubMed ID: 1732046
[TBL] [Abstract][Full Text] [Related]
20. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
